"The U.S. Food and Drug Administration today approved Cosentyx (secukinumab) to treat adults with moderate-to-severe plaque psoriasis.
Psoriasis is a skin condition that causes patches of skin redness and irritation. Psoriasis is"...
The local adverse reactions which were reported with DIPROLENE Lotion (betamethasone dipropionate) during controlled clinical trials were as follows: erythema, folliculitis, pruritus and vesiculation each occurring in less than 1 % of patients.
The following additional local adverse reactions have been reported with topical corticosteroids, and they may occur more frequently with the use of occlusive dressings and higher potency corticosteroids.
These reactions are listed in an approximately decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, skin atrophy, striae and miliaria.
Systemic absorption of topical corticosteroids has produced reversible hypothalamic-pituitary-adrenal (HPA) axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria in some patients.
Read the Diprolene Lotion (betamethasone dipropionate) Side Effects Center for a complete guide to possible side effects
No information provided.
Last reviewed on RxList: 6/2/2009
This monograph has been modified to include the generic and brand name in many instances.
Additional Diprolene Lotion Information
Diprolene Lotion - User Reviews
Diprolene Lotion User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.